Q BioMed signs definitive license agreement for Mannin's platform technology assets Nov. 3, 2015 No Comments
Quark Pharmaceutical begins patient recruitment for global pivotal study of QPI-1007 Oct. 29, 2015 No Comments
OPUS-3 trial of lifitegrast meets primary and key secondary endpoints for dry eye Oct. 28, 2015 No Comments
Phase I trial of ISIS-GSK4-LRx triggers milestone payment to Isis Pharmaceuticals Oct. 27, 2015 No Comments
Targeting retinal VEGR receptors, a promising strategy for retinal angiogenesis disorders Oct. 27, 2015 No Comments
Applied Genetic Technologies' gene therapy product receives E.U. orphan drug designation Oct. 26, 2015 No Comments
RSS